Post job

CRISPR Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
304
Founded in
Organization type
Public
Social media
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeutics' vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.
Based in Cambridge, MA, CRISPR Therapeutics is a medium-sized health care company with 304 employees and a revenue of $37.3M.

CRISPR Therapeutics's mission statement

To develop transformative gene-based medicines for patients with serious diseases. Our therapeutic approach aims to cure diseases at the molecular level using the breakthrough gene editing technology called CRISPR-Cas9.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

CRISPR Therapeutics employee reviews

Be the first to review!

Do you work at CRISPR Therapeutics?

Help job seekers learn about working at CRISPR Therapeutics

Job openings at CRISPR Therapeutics
34 positions

On this page

Be the first to review CRISPR Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at CRISPR Therapeutics?

The team at CRISPR Therapeutics

  • The founders of CRISPR Therapeutics are Dr. Rodger Novak, Emmanuelle Charpentier, Shaun Foy, Chad Cowan, Craig Mello, Daniel Anderson and Dr. Matthew Porteus.
  • The key people at CRISPR Therapeutics are Samarth Kulkarni, Dr. Rodger Novak and Emmanuelle Charpentier.
Key people
Samarth Kulkarni
Dr. Rodger Novak
Emmanuelle Charpentier
Shaun Foy
Chad Cowan
Craig Mello
Daniel Anderson
Dr. Matthew Porteus

CRISPR Therapeutics rankings

CRISPR Therapeutics is ranked #58 on the Best Health Care companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

CRISPR Therapeutics salaries

Average CRISPR Therapeutics salary
$82,541
yearly
$39.68 hourly
Updated March 14, 2024

Rate the CRISPR Therapeutics' inclusivity.

Zippia waving zebra

Do you work at CRISPR Therapeutics?

Did CRISPR Therapeutics' compensation package meet your expectations?

CRISPR Therapeutics financial performance

9.8
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

CRISPR Therapeutics currently has 1.2M in revenue. CRISPR Therapeutics's most recent quarter produced 70.0m (q2'2023).

CRISPR Therapeutics annual revenue

$915M
$732M
$549M
$366M
$183M
$0
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at CRISPR Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

CRISPR Therapeutics FAQs

Search for jobs

Most common locations at CRISPR Therapeutics

Most common jobs at CRISPR Therapeutics

Zippia gives an in-depth look into the details of CRISPR Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CRISPR Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at CRISPR Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CRISPR Therapeutics. The data presented on this page does not represent the view of CRISPR Therapeutics and its employees or that of Zippia.

CRISPR Therapeutics may also be known as or be related to CRISPR THERAPEUTICS AG, CRISPR Therapeutics, CRISPR Therapeutics AG, Crispr Therapeutics and Crispr Therapeutics, Inc.